DaVita Comprehensive Income 2010-2024 | DVA
DaVita comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- DaVita comprehensive income for the quarter ending September 30, 2024 was $-0.162B, a 135.61% increase year-over-year.
- DaVita comprehensive income for 2023 was $-0.052B, a 24.72% decline from 2022.
- DaVita comprehensive income for 2022 was $-0.069B, a 50.31% decline from 2021.
- DaVita comprehensive income for 2021 was $-0.139B, a 110.49% increase from 2020.
DaVita Annual Comprehensive Income
(Millions of US $) |
| 2023 |
$-52 |
| 2022 |
$-69 |
| 2021 |
$-139 |
| 2020 |
$-66 |
| 2019 |
$-47 |
| 2018 |
$-35 |
| 2017 |
$13 |
| 2016 |
$-90 |
| 2015 |
$-60 |
| 2014 |
$-25 |
| 2013 |
$-3 |
| 2012 |
$-15 |
| 2011 |
$-19 |
| 2010 |
$1 |
| 2009 |
$-6 |
DaVita Quarterly Comprehensive Income
(Millions of US $) |
| 2024-09-30 |
$-162 |
| 2024-06-30 |
$-195 |
| 2024-03-31 |
$-100 |
| 2023-12-31 |
$-52 |
| 2023-09-30 |
$-69 |
| 2023-06-30 |
$-7 |
| 2023-03-31 |
$-55 |
| 2022-12-31 |
$-69 |
| 2022-09-30 |
$-136 |
| 2022-06-30 |
$-112 |
| 2022-03-31 |
$-35 |
| 2021-12-31 |
$-139 |
| 2021-09-30 |
$-120 |
| 2021-06-30 |
$-66 |
| 2021-03-31 |
$-123 |
| 2020-12-31 |
$-66 |
| 2020-09-30 |
$-123 |
| 2020-06-30 |
$-135 |
| 2020-03-31 |
$-141 |
| 2019-12-31 |
$-47 |
| 2019-09-30 |
$-78 |
| 2019-06-30 |
$-34 |
| 2019-03-31 |
$-48 |
| 2018-12-31 |
$-35 |
| 2018-09-30 |
$-29 |
| 2018-06-30 |
$-22 |
| 2018-03-31 |
$27 |
| 2017-12-31 |
$13 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$-27 |
| 2017-03-31 |
$-77 |
| 2016-12-31 |
$-90 |
| 2016-09-30 |
$-52 |
| 2016-06-30 |
$-60 |
| 2016-03-31 |
$-54 |
| 2015-12-31 |
$-60 |
| 2015-09-30 |
$-54 |
| 2015-06-30 |
$-44 |
| 2015-03-31 |
$-48 |
| 2014-12-31 |
$-25 |
| 2014-09-30 |
$-12 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$-2 |
| 2013-12-31 |
$-3 |
| 2013-09-30 |
$-4 |
| 2013-06-30 |
$-3 |
| 2013-03-31 |
$-17 |
| 2012-12-31 |
$-15 |
| 2012-09-30 |
$-18 |
| 2012-06-30 |
$-19 |
| 2012-03-31 |
$-19 |
| 2011-12-31 |
$-19 |
| 2011-09-30 |
$-21 |
| 2011-06-30 |
$-12 |
| 2011-03-31 |
$-2 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$-6 |
| 2009-09-30 |
$-8 |
| 2009-06-30 |
$-10 |
| 2009-03-31 |
$-12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$12.872B |
$12.140B |
|
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
|
